C.P. Pharmaceuticals International

C.P. Pharmaceuticals International C.V. is a major international subsidiary of Pfizer, serving as a primary holding and operating entity for the parent company's global pharmaceutical business. Based in the Netherlands, the company is central to Pfizer's international corporate structure, often holding intellectual property rights and managing manufacturing and distribution agreements for a wide range of therapies. Its operations support Pfizer's core therapeutic areas, including oncology, immunology, cardiology, and infectious diseases. The entity is frequently involved in high-profile regulatory filings and strategic partnerships, such as the collaboration with BioNTech for COVID-19 vaccines. As a key component of Pfizer's global reach, it facilitates the commercialization of blockbuster products like Comirnaty, Paxlovid, and Ibrance.